Fundz

Stemgenics, Inc. reported raising $445,000 in an initial SEC Form D filing, from an offering of $20 Million

PRIVATEJul 20, 2018$445K of $20M raised

Amount Raised

$445,000

$445,000 sold, per SEC Form D (first sale Jul 20, 2018)

Round Type

Seed

SeattleBiotechnology

Quick answer

Stemgenics, Inc. raised $445,000 in a Seed round, dated July 20, 2018. Stemgenics, Inc. is based in Seattle, Washington, United States.

How much did Stemgenics, Inc. raise?
Stemgenics, Inc. raised $445,000 in a Seed round on July 20, 2018.
What does Stemgenics, Inc. do?
Stemgenics has developed a breakthrough technology that converts mature cells (skin cells) into personalized stem cells.
Where is Stemgenics, Inc. based and how big is it?
Stemgenics, Inc. is based in Seattle, Washington, United States.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Stemgenics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • BennuBio raised $500K (Seed) on August 31, 2018.
  • Amyris raised $91M on August 31, 2018.
  • Phoenix Cardiac Devices, Inc. raised $2.1M (Seed) on August 31, 2018.
  • EXICURE, INC. raised $22M on August 31, 2018.
  • PATHOVAX LLC raised $2.8M (Seed) on August 31, 2018.
  • Neopenda, PBC raised $20K (Pre-Seed) on August 30, 2018.

Who to call at Stemgenics, Inc., and when

A new round usually means Stemgenics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Stemgenics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Stemgenics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Stemgenics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Stemgenics, Inc.

Location

454 N. 34TH STREET

Seattle, Washington, United States

About

Stemgenics has developed a breakthrough technology that converts mature cells (skin cells) into personalized stem cells.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Stemgenics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Stemgenics, Inc.'s next move

See what Strategic adds

Stemgenics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.